Details:

Personal Author:
Ward, John W. ; Burk, Katie ; Page, Kimberly ; Cowie, Benjamin C. ; Iskander, John K. ; ... More +
Ward, John W. ; Burk, Katie ; Page, Kimberly ; Cowie, Benjamin C. ; Iskander, John K. ; Thorpe, Phoebe ; Laird, Susan Less -
Corporate Authors:
Centers for Disease Control and Prevention (U.S.). Office of the Associate Director for Communication. ; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.)
Centers for Disease Control and Prevention (U.S.). Office of the Associate Director for Communication. ; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.) Less -
Description:
April 17, 1:00pm ET

Viral hepatitis, a group of infectious diseases, affects millions of people worldwide. The World Health Organization (WHO) estimates 325 million people worldwide are living with chronic hepatitis B or chronic hepatitis C. Deaths due to viral hepatitis reached 1.34 million in 2015, comparable to the number of deaths caused by tuberculosis and HIV. Yet, effective measures such as educational programs for people who inject drugs and ensuring infants born to hepatitis B infected mothers are vaccinated against hepatitis B would dramatically reduce hepatitis B and C infections worldwide.

This session of Public Health Grand Rounds discussed how new therapies and technologies can be used to eliminate hepatitis B and C. Learn how multiple approaches and working with health partners can help reach the goals of eliminating these diseases. Find out about the promising work that Australia, the state of New Mexico, and the city of San Francisco are doing.

Presented by: John Ward, MD, Program Director, Viral Hepatitis Elimination, Task Force for Global Health, Senior Scientist, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention ["New Goals to Eliminate Hepatitis B and C"]; Katie Burk, MPH, Viral Hepatitis Coordinator , San Francisco Department of Health ["Collaborations and Strategies to Eliminate Hepatitis B and C in San Francisco"]; Kimberly Page, PhD, MPH, Professor and Chief, Division of Epidemiology, Biostatistics and Preventive Medicine, University of New Mexico Health Sciences ["Placing New Mexico on the Path to HCV Elimination"]; Benjamin Cowie, MBBS, PhD, FRACP, Director, WHO Collaborating Centre for Viral Hepatitis, Doherty Institute , Consultant PhysicianVictorian Infectious Diseases Service, Royal Melbourne Hospital, Associate Professor, The University of Melbourne ["Progress towards Hepatitis B and C Elimination in Australia"].

Facilitated by: John Iskander, MD, MPH, Scientific Director, Public Health Grand Rounds; Phoebe Thorpe, MD, MPH, Deputy Scientific Director, Public Health Grand Rounds; Susan Laird, MSN, RN, Communications Director, Public Health Grand Rounds.


Content Notes:
Global Progress [PDF version of the PowerPoint presentation by Anagha Loharikar, p. 3-30] -- Global Progress [PDF version of the PowerPoint presentation by Carsten Mantel, p. 31-55] -- Financial and Economic Considerations [PDF version of the PowerPoint presentation by George S. Schroeder, p. 56-71].
Subject:
[+]
Coinfection/epidemiology Hepatitis B, Chronic Hepatitis C, Chronic Substance Abuse, Intravenous
Series:
CDC Public health grand rounds ; 2018 April 17
Document Type:
Presentation
Genre:
Webcasts
Collection(s):
Stephen B. Thacker CDC Library collection
Main Document Checksum:
[+]
urn:sha256:b0ad7052b8b1a1f52ed6f2c2e168d53b71dd2277b094291834cf140a34b46529
Download URL:
https://stacks.cdc.gov/view/cdc/53559/cdc_53559_DS1.pdf
File Type:

Supporting Files

• 	Beyond the Data - Working Together to Eliminate the Threat of Hepatitis B and C	htm
  	Working Together to Eliminate the Threat of Hepatitis B and C	htm

More +